Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer

INTRODUCTION: Bone metastases are frequent in patients with non-small cell lung cancer (NSCLC). The receptor activator of Nuclear Factor κB (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) pathway is important in bone metastases development. Furthermore, epidermal growth factor receptor (EGFR) signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouns, Anita J.W.M., Hendriks, Lizza E.L., Robbesom-van den Berge, Iris J., Driessen, Annemariek J.H.M., Roemen, Guido M.J.M., van Herpen, Britt L.J., Dekkers, Zoë, Heitzer, Bas, Leunissen, Daphne J.G., Moonen, Laura, Lunde, Ragnar, Westenend, Marcel, van Driel, Marjolein, Speel, Ernst-Jan M., Dingemans, Anne-Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196450/
https://www.ncbi.nlm.nih.gov/pubmed/37213294
http://dx.doi.org/10.3389/fonc.2023.1145001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196450/
https://www.ncbi.nlm.nih.gov/pubmed/37213294
http://dx.doi.org/10.3389/fonc.2023.1145001

Ejemplares similares